FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to gynaecology, and may be used for treating cystic fibrosis of the breast in females of reproductive age. That is ensured by prescribing the burdock root extract Toxidont-May in a dose of 1 teaspoon in 1 glass of warm water 3 times a day for 3 months.
EFFECT: method provides higher clinical effectiveness ensured by anti-oestrogen actions of the preparation caused by stimulating formation of antiproliferative 2OHE1 in hormone-dependent tissues and improving thereby the relation 2-OHE1/16αOHE1 in favour of the first with no side effects.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING CYSTIC FIBROSIS OF BREAST IN FEMALES OF REPRODUCTIVE AGE | 2011 |
|
RU2456009C1 |
| METHOD OF TREATING VEGETATIVE DYSFUNCTION ACCOMPANYING DIFFUSE CYSTIC FIBROSIS OF BREAST IN FEMALES OF REPRODUCTIVE AGE | 2011 |
|
RU2471494C2 |
| METHOD OF TREATING DIFFUSE MAMMARY DYSPLASIA IN FEMALES OF REPRODUCTIVE AGE | 2013 |
|
RU2548723C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF FIBROCYSTIC DISEASE FORMS IN WOMEN WITH PRESERVED REPRODUCTIVE FUNCTION | 2010 |
|
RU2452389C1 |
| METHOD OF TREATING DIFFUSE BENIGN BREAST DYSPLASIA | 2018 |
|
RU2702010C1 |
| METHOD FOR TREATING MASTOPATHY | 2002 |
|
RU2226400C1 |
| METHOD FOR PREDICTION OF DEVELOPING COMPLICATIONS IN WOMEN SUFFERING CLIMACTERIC SYNDROME AND MASTOPATHY AND EMPLOYING HORMON REPLACEMENT | 2010 |
|
RU2426994C1 |
| METHOD FOR DETERMINING EFFECTIVENESS OF DOSE OF DIETARY SUPPLEMENT LIGNARIUS IN PATIENTS WITH FIBROCYSTIC MASTOPATHY | 2022 |
|
RU2806529C1 |
| BREAST CYST FORMATIONS CLASSIFICATION | 2017 |
|
RU2639804C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PROLIFERATIVE MAMMARY GLAND DISEASES | 2005 |
|
RU2318508C2 |
